Most lately, it's been discovered that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in identical locations as classical opioid receptors, it binds to some big selection of endogenous opioids. Unlike most opioid receptors, this receptor acts like a scavenger and won't activate https://hilarye925igb4.oblogation.com/profile